KURE – KraneShares MSCI All China Health Care Index ETF
KraneShares MSCI All China Health Care Index ETF (KURE) is a China Region ETF, issued by KraneShares, $82.5M in assets, 0.65% expense ratio.
Returns as of Oct 23, 2026: 1 week +1.1%, 1 year +34.5%.
Tracks MSCI All China Health Care Index, focusing on Chinese healthcare companies. Market cap weighted, subject to 10/40 constraint.
Top holdings
- 600276 – Jiangsu Hengrui Medicine Co Ltd, 8.1%
- 1801 – Innovent Biologics Inc, 7.5%
- 2269 – WuXi Biologics, 7.3%
- 9926 – Akeso Inc, 4.6%
- 300760 – Shenzhen Mindray Bio-Medical Electronics Co Ltd Class A, 4.5%
- 1177 – Sino Biopharmaceutical Ltd, 4.2%
- 3692 – Hansoh Pharmaceutical Group Co Ltd, 3.8%
- 1093 – CSPC Pharmaceutical Group Ltd, 3.8%
- 603259 – WuXi AppTec Co Ltd, 2.9%
- 1530 – 3SBio Inc, 2.8%
- 300015 – Aier Eye Hospital Group, 2.2%
- 000538 – Yunnan Baiyao Group Co Ltd, 2.1%
- 600436 – Zhangzhou Pientzehuang Pharmaceutical Co Ltd, 2.1%
- 1099 – Sinopharm Group Co Ltd, 1.7%
- 2359 – WuXi AppTec Co Ltd H, 1.6%
- 000963 – Huadong Medicine Co Ltd, 1.4%
- 2268 – WuXi XDC Cayman Inc, 1.4%
- 600196 – Shanghai Fosun Pharmaceutical Group Co Ltd, 1.2%
- 002294 – Shenzhen Salubris Pharmaceuticals Co Ltd, 1.2%
- 0999 – Xiaocaiyuan Intl Hldg Ltd, 1.1%
- 002422 – Sichuan Kelun Pharmaceutical Co Ltd, 1.1%
- 002653 – Xizang Haisco Pharmaceutical Group Co Ltd, 1.0%
- 1548 – Genscript Biotech Corp, 1.0%
- 601607 – Shanghai Pharmaceuticals Holding Co Ltd, 1.0%
- 000999 – China Resources Sanjiu Medical & Pharmaceutical Co Ltd, 1.0%